388MO Tumor budding, an important prognostic factor in stage III colon cancer patients treated with oxaliplatin-based chemotherapy

Autor: Basile, D., Broudin, C., Emile, J-F., Falcoz, A., Toullec, C., Bennouna, J., Louvet, C., Desrame, J., Fratte, S., André, T., Taieb, J., Svrcek, M.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S533-S533
Databáze: ScienceDirect